Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
15.91
+0.26 (1.66%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Takeda Pharmaceutical Employees
Takeda Pharmaceutical Company had 47,029 employees as of March 31, 2026. The number of employees decreased by 426 or -0.90% compared to the previous year.
Employees
47,029
Change (1Y)
-426
Growth (1Y)
-0.90%
Revenue / Employee
$602,542
Profits / Employee
-$20,379
Market Cap
49.71B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 47,029 | -426 | -0.90% |
| Mar 31, 2025 | 47,455 | -1,826 | -3.71% |
| Mar 31, 2024 | 49,281 | 186 | 0.38% |
| Mar 31, 2023 | 49,095 | 1,748 | 3.69% |
| Mar 31, 2022 | 47,347 | 248 | 0.53% |
| Mar 31, 2021 | 47,099 | -396 | -0.83% |
| Mar 31, 2020 | 47,495 | -2,083 | -4.20% |
| Mar 31, 2019 | 49,578 | 22,348 | 82.07% |
| Mar 31, 2018 | 27,230 | -2,670 | -8.93% |
| Mar 31, 2017 | 29,900 | -1,268 | -4.07% |
| Mar 31, 2016 | 31,168 | -160 | -0.51% |
| Mar 31, 2015 | 31,328 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Teva Pharmaceutical Industries | 33,950 |
| Viatris | 30,000 |
| Dr. Reddy's Laboratories | 27,527 |
| Haleon | 24,535 |
| Zoetis | 14,500 |
| Elanco Animal Health | 9,900 |
| Hims & Hers Health | 2,442 |
| Alkermes | 2,050 |
TAK News
- 4 days ago - Takeda Appoints Julie Kim President & CEO Following 18-Month Transition As Weber Retires - Nasdaq
- 4 days ago - Takeda CEO Christophe Weber retires, Julie Kim succeeds - TheFly
- 4 days ago - Takeda Names Julie Kim CEO As Christophe Weber Retires - Nasdaq
- 4 days ago - Takeda Announces New Assignments of Directors and Appointment of Julie Kim as Representative Director, President and CEO - Business Wire
- 4 days ago - Takeda Canada reports ‘positive’ results from Phase 3 study of zasocitinib - TheFly
- 4 days ago - Takeda Canada Announces Positive Topline Results For Phase 3 LATITUDE Atlas Study For Psoriasis - Nasdaq
- 12 days ago - Takeda Releases New Positive Phase 3 FirstLight And RadiantLight Data For Oveporexton In Narcolepsy - Nasdaq
- 12 days ago - Takeda presents additional results from oveporexton studies at SLEEP 2026 - TheFly